WallStSmart
GRFS

Grifols SA ADR

NASDAQ: GRFS · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

$7.91
-1.98% today

Updated 2026-04-29

Market cap
$5.38B
P/E ratio
11.46
P/S ratio
0.72x
EPS (TTM)
$0.69
Dividend yield
2.22%
52W range
$7 – $11
Volume
0.8M

Grifols SA ADR (GRFS) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-19.3%
Last 4 quarters
Revenue YoY growth
-0.6%
Most recent quarter
EPS YoY growth
+167.4%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-0.8%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
-8.5%
2025-11-04
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-24$0.29+0.8%$9.07$9.25+2.0%
2025-11-04$0.21-12.8%$9.43$8.63-8.5%
2025-07-28$0.22-21.4%$10.10$10.50+4.0%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.29$0.29+0.8%$1.96B-0.6%
2025-09-30$0.24$0.21-12.8%$1.87B+4.0%
2025-06-30$0.28$0.22-21.4%$1.89B+4.0%
2025-03-31$0.16$0.09-43.9%$1.79B+9.8%
2024-12-31$0.23$0.11-52.7%$1.98B+11.7%
2024-09-30$0.24$0.17-29.2%$1.79B+12.2%
2024-06-30$0.21$0.15-28.6%$1.82B+9.3%
2024-03-31$0.15$0.07-53.3%$1.63B
2023-12-31$0.22$0.14-36.4%$1.77B
2023-09-30$0.22$0.11-50.0%$1.60B
2023-06-30$0.16$0.16+3.1%$1.66B

Frequently asked questions

Has Grifols SA ADR beaten earnings estimates?
Grifols SA ADR has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of -19.3% over the last 4 quarters.
How does GRFS stock react to earnings?
GRFS stock has moved an average of -0.8% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Grifols SA ADR's revenue growth rate?
Grifols SA ADR reported year-over-year revenue growth of -0.6% in its most recent quarter, with EPS growing +167.4% year-over-year.